Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPERA antidepressant discontinuation trial
NL-OMON25860Not yet recruiting
- Sponsor
- ZonMW, grant number: 80-84800-98-40002
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of citalopram and sertraline in major depressive disorder (MDD) (3 arms), sponsored by ZonMW, grant number: 80-84800-98-40002. Primary endpoint: Sustained remission time. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
citalopramsertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON25860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25860.